Alere Takes Over Arriva - Analyst Blog
30 11월 2011 - 9:00PM
Zacks
Alere (ALR), a
medical products company focused on integrating rapid diagnostics
with health management, recently revealed that it has taken over
Arriva Medical, a prominent vendor of diabetes testing supplies for
patients residing at home.
Florida-based Arriva had sales of
about $21.5 million for the half year ending October 31, 2011. The
company delivers diabetes supplies right to the patient’s home. It
completes claim forms and bills Medicare as well as the
supplemental insurance company for the patient.
Alere paid about $65 million in
cash to acquire Arriva, besides 806,452 restricted shares of its
common stock. The deal is subject to working capital and various
closing adjustments.
By acquiring Arriva, Waltham-based
Alere acquires fresh abilities to handle near-patient treatment.
Alere’s expertise and product development efforts center around
women’s health, infectious disease, cardiology, toxicology and
oncology.
Diagnostic tests are shifting
closer to the consumers and into the home testing market, as more
diagnostic tests are being developed to monitor patients rather
than simply diagnose them. Alere's strategy of combining disease
management with point-of-care testing (“POCT”), in a manner that
encourages patients to take responsibility over their overall
health care, is viewed as a prudent approach while at the same time
ensuring affordability.
In addition to growing its revenues
through a combination strategy of continued acquisitions and
measured organic growth, the company is committed to improving its
operating margin. Further, its product pipeline is strong, which
has been developed through a combination of internal R&D as
well as serial acquisitions. One of the company’s competitors is
Abaxis (ABAX).
ABAXIS INC (ABAX): Free Stock Analysis Report
ALERE INC (ALR): Free Stock Analysis Report
Zacks Investment Research
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Abaxis, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Abaxis, Inc. (MM) News Articles